🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Piper Sandler lifts Sight Sciences stock target on Q1 sales beat

EditorAhmed Abdulazez Abdulkadir
Published 03/05/2024, 15:24
SGHT
-

On Friday, Sight Sciences Inc. (NASDAQ: NASDAQ:SGHT) received an updated price target from Piper Sandler, following the company's first-quarter earnings report. The new price target is set at $6.00, increased from the previous $5.00, while the firm maintained a Neutral rating on the stock.

Sight Sciences reported quarterly results that surpassed expectations, primarily driven by its surgical glaucoma products. The company's management pointed out that the use of their Omni device has grown both sequentially and year-over-year, indicating a potential uptick in business activity.

Despite the stronger than anticipated first-quarter performance, Sight Sciences chose to maintain its sales guidance for the year. Analysts interpret this move as a cautious stance, considering the early phase of the fiscal year. The company expects low double-digit growth in the second quarter.

InvestingPro Insights

Following the upbeat first-quarter earnings report from Sight Sciences Inc. (NASDAQ: SGHT), investors may be seeking further context to gauge the company's financial health and market performance. InvestingPro data highlights a market capitalization of $283.55 million, indicating the company's size within its sector. Despite a challenging profitability outlook, with a P/E ratio of -4.99 and an adjusted P/E ratio for the last twelve months as of Q1 2024 at -5.32, Sight Sciences has demonstrated robust revenue growth of 8.27% over the same period.

InvestingPro Tips suggest a mixed financial picture. On the positive side, Sight Sciences holds more cash than debt, which is a sign of financial stability, and liquid assets exceed short-term obligations, providing some financial flexibility. Additionally, 4 analysts have revised their earnings upwards for the upcoming period, reflecting a potential improvement in the company's earnings outlook. However, it's important to note that Sight Sciences is not expected to be profitable this year and has been quickly burning through cash. Despite these challenges, the company has seen a strong return over the last three months, with a price total return of 30.77%, and an impressive six-month price total return of 208.24%.

For investors looking for more in-depth analysis, there are 9 additional InvestingPro Tips available, which can be accessed by visiting https://www.investing.com/pro/SGHT. To enrich your investment decisions, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.